SCHEMBL16769397

SCHEMBL16769397

CCCCCCc1ccc(-c2nc(-c3ccc(C)c(C)c3)nc(-c3ccc(C)c(C)c3C)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 8/20 0.47
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 3/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
USP2 O75604 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RARA P10276 1/20 0.40
MTOR P42345 1/20 0.40
SPHK1 Q9NYA1 2/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
HSD11B1 P28845 1/20 0.39
TSHR P16473 1/20 0.38
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16769374 0.90 ALDH1A1 (0.52) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769386 0.90 ALDH1A1 (0.52) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769383 0.88 RARB (0.53) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL15281189 0.86 RARB (0.57) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769399 0.85 RARB (0.42) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769384 0.82 RARB (0.53) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769380 0.82 RARB (0.53) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL12128008 0.80 RARB (0.53) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769409 0.80 RARB (0.44) RARBALDH1A1HSD17B10MEN1MAPT
SCHEMBL16769378 0.80 RARB (0.48) RARBALDH1A1HSD17B10MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9905767-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-27 US disclosed
US-9853218-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-26 US disclosed
US-20150207077-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-23 US disclosed
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME ARL1, CCNL2, CRKL RARB 658/4885ALDH1A1 806/4885HSD17B10 3991/4885
US-20150207077-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME ARL1, GRK1, GNA11 RARB 609/4885ALDH1A1 315/4885HSD17B10 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.